Bovine papillomatosis is characterised by the appearance of cutaneous, mucosal, and genital warts. It is caused by non-enveloped icosahedral bovine papillomavirus (BPV), which possesses an 8-kb circular double-stranded DNA genome. The virus has a 1–3-month incubation period and occurs primarily at an early age, although infection and wart onset can occur at any age (26). It enters through a skin wound and is disseminated by direct or indirect contact, through interaction with the major and minor viral proteins L1 and L2 (17, 28, 29). The risk of developing papillomatosis increases with immunosuppression and declining animal health (13). Bovine papillomavirus has 24 reported genotypes, 1, 2, and 4 being the most prevalent ones in cattle worldwide (1). Types 1 and 2 belong to the
Synthetic peptides used to prevent diseases have become an important strategy in immunisation protocols for disease control. A peptide derived from the N-terminal L2 minor protein of BPV-4 has been evaluated in a bovine model for prophylactic purposes and shown to reduce the number and size of warts (2). In describing how they modelled the human papillomavirus (HPV) capsid, Modis
Bovine papillomatosis prevalence in Nuevo León, Chiapas, Veracruz and Tabasco, Mexico
State: | Papillomatosis | n |
---|---|---|
Nuevo León | ||
Farm 1 (Linares) | 3.77% | 450 |
Farm 2 (Linares) | 18% | 250 |
Farm 3 (Cadereyta) | 11.43% | 700 |
Chiapas | ||
Farm 4 (Palenque) | 12.83% | 1200 |
Farm 5 (Libertad) | 11.6% | 500 |
Farm 6 (Salto de Agua) | 32.8% | 125 |
Farm 7 (Agua Fria) | 20% | 50 |
Veracruz | ||
Farm 8 (Temapache) | 10.67% | 150 |
Farm 9 (Tihuatlán) | 10% | 160 |
Tabasco | ||
Farm 10 (Emiliano Zapata) | 9.2% | 1500 |
Farm 11 (Balancan) | 16.25% | 80 |
Farm 12 (Tenosique) | 23.44% | 320 |
n – total sampled bovines per farm of all ages
The southern states showed higher prevalence levels (Tabasco farms having 9.2% to 23.44%, Chiapas 11.6% to 32.8% and Veracruz 10% and 11%) than the northern state of Nuevo León (3.77% to 11.43%) (Table 1). Most representative samples that were subjected to genotyping by PCR presented BPV-1 (96.88% of all samples, 37.50% in this percentage presenting exclusively BPV-1) and a minor part presented BPV-2 (this variant only occurring as a co-infection with BPV-1, comprising the remaining 59.38% in the 96.88%) (Figs 1 and 3). The genotype could not be identified in two samples from Tabasco and Chiapas (Figs 2 and 3) even though they presented the cauliflower morphology characteristic of BPV warts.
Bovine papillomavirus BPV-1 and BPV-2 shown in representative samples which were positive for viral genetic material when electrophoresed in 1.5% agarose gel
M – 100 base pair molecular weight marker; C+ – BPV-1 positive sample from Nuevo León; C− – DNA-free reaction mix; A – BPV-1 presence in cutaneous/genital warts: lanes 1–11, 13–14 and 16–25; B – BPV-2 presence in cutaneous/genital warts: lanes 8–11, 13–14 and 18–25 (Nuevo León, lanes 1–5 and 24–25; Veracruz, 18–23; Chiapas, 6–7 and 14–17; and Tabasco, 8–13)
Samples negative for bovine papillomavirus (BPV)-1/2/4 and therefore with genotype unknown A – sample from Emiliano Zapata, Tabasco; B – sample from Libertad, Chiapas. Samples had cauliflower morphology suggesting that they be considered BPV positive
Bovine papillomavirus (BPV)-1 and BPV-2 genotype distribution per state from representative samples. BPV-1 was found as a unique genotype or as a co-infection with BPV-2, but BPV-2 was found only as a co-infection
Genotypes were confirmed by sequencing, selecting those with an A260 : 280 absorbance ratio of 1.8 indicating high purity when extracted. Alignment of sequences in BLASTn revealed high homology between each obtained genotype sequence and that of the corresponding genotype recorded in the NCBI database (Tables 2 and 3); BPV-1 sequences showed higher homology (99%) with their corresponding sequences than BPV-2 sequences (91–97%) (Tables 2 and 3) against the reference sequences with accession number KC595244.2 and MH187961.1, for that the virus genotype 2 sequences were still identifiable and conserved, which made the genotypes identified by PCR certain to be the correct ones. Phylogenetic analysis located Mexican sequences in exclusive clades (Figs 4 and 5), although the BPV-1 phylogenetic tree separated local sequences into three clades instead of one monophyletic group, as was observed in the BPV-2 phylogenetic tree (Fig. 5). In the analysis of the partial sequences of the L1 protein, it was observed that all the clades started from the same node from which the HPV-16 sequence separated from the bovine sequences, showing a common ancestor located at the root, and a closer relationship between the BPV-1 sequences than these sequences had to the reference one, which was another confirmation of the identity of the local sequences obtained. All the BPV-1 sequences were equally related as they had the same distance from the common ancestor (three nodes), but it was observed that the sequences from countries other than Mexico were in an exclusive clade, which shows that they are more related. Local sequences, on the other hand, were found in three clades mixing the different states, two of these at the same distance from the common ancestor, and a clade composed of two sequences from the state of Nuevo León was found slightly further away from this ancestor. Regarding the sequences derived from the L2 minor viral capsid protein, the Veracruz local sequence (Veracruz RS20) was in an exclusive clade along with the common ancestor, whereas the Tabasco sequence (Tabasco RS8) was found in another exclusive clade at greater distance from the common ancestor; both local sequences were separated from international ones (Fig. 5). It was demonstrated that the sequences obtained from local states were conserved but still highly related to sequences from around the world.
Bovine papillomavirus (BPV)-1 phylogenetic tree of Mexican isolates (partial L1 sequence). Sequences were compared with sequences from different nationalities recorded in the NCBI database, of which the accession numbers are indicated. The comparison used a neighbour-joining method in MEGA 10.1. RS – representative sample
Bovine papillomavirus (BPV)-2 phylogenetic tree of Mexican isolates (partial L2 sequence). Sequences were compared with sequences from different nationalities recorded in the NCBI database, of which the accession numbers are indicated. The comparison used a neighbour-joining method in MEGA 10.1. RS – representative sample
Nucleotide sequence identity analysis of bovine papillomavirus 1 L1 fragments isolated from samples positive for the virus
Sequence | Expect (E) value | Identity % (alignment with KC595244.2) | Gaps |
---|---|---|---|
Chiapas (RS7) | 7e−129 | 99% | 2/265 |
Chiapas (RS6) | 4e−118 | 99% | 0/242 |
Nuevo León (RS4) | 2e−129 | 99% | 3/267 |
Nuevo León (RS2) | 2e−101 | 99% | 0/209 |
Nuevo León (RS5) | 3e-131 | 99% | 2/266 |
Veracruz (RS20) | 1e−125 | 99% | 1/257 |
Tabasco (RS8) | 1e−125 | 99% | 1/257 |
Nuevo León (RS3) | 2e−126 | 99% | 2/261 |
Nuevo León (RS1) | 6e−128 | 99% | 4/267 |
Nucleotide sequence identity analysis of bovine papillomavirus 2 L2 fragments isolated from samples positive for the virus
Sequence | Expect (E) value | Identity % (alignment with MH187961.1) | Gaps |
---|---|---|---|
Veracruz (RS20) | 7e−25 | 97% | 0/71 |
Tabasco (RS8) | 6e−45 | 91% | 3/132 |
Chiapas was the state with the lowest percentage of co-infections at 18.75%, followed by Nuevo León at 25%, Tabasco at 93.75%, and Veracruz at 100% (Figs 3 and 6). It is important to mention that Veracruz is one of the largest cattle collection centres, and larger than Tabasco and Chiapas. Meanwhile Nuevo León is the final feedlot destination for exportation or national consumption as it is in the north of the country (Fig. 6). It is remarkable that, as cattle move north, the co-infection ratio decreases. Nuevo León acts as a bottleneck by virtue of its position in selecting cattle, whereas Veracruz concentrates the incoming genotypes from South American countries and the concentration facilitates virus transmission.
Geographical bovine papillomavirus (BPV) genotype localisation in Mexico. Tabasco, Chiapas, and Veracruz states are considered breeder states and cattle collection centres for Central America. Nuevo León is a final feedlot destination state for national consumption or international exportation. The intensity of grey indicates the percentage of co-infection
A – Chiapas; B – Tabasco; C – Veracruz; D – Nuevo León
Once the circulating genotypes (Fig. 6) were identified, and the sequences analysed transpired to be highly conserved locally and internationally, a candidate peptide was selected for immunisation in the mouse model with the purpose of antibody production. The selected peptide was derived from BPV-1 and BPV-2 genotypes. Peptide selection was based on the matches between the outputs of online servers of the C-terminal region of the L1 protein amino acid sequence, considering the higher scores (Table 4 and Fig. 7). The sequence measures 14 nucleotides to fit the B-cell epitope length. Figure 9B shows a yellow region indicating antigenicity and green non-antigenic regions within the peptide; most of the C-terminal region was shown to be antigenic. Because the immunisation experiment was to be performed in a mouse model, affinity with this was verified with B cell epitope prediction in Bepipred IDBT software. The
Candidate peptide prediction by online server. The amino acid sequence of the selected peptide possesses antigenicity. Prediction with default values was performed in Bepipred Linear Epitope Predictor
Specificity of the candidate peptide for BPV-1. BLASTp showed it to be specific to BPV-1 and BPV-2 with 100% homology
Sera reactivity against WWL/synthetic peptide and antibody specificity against BPV
A – Anti-wart antibody reactivity against WWL at 1: 100 dilution on day 7 and 1:10,000 on days 14 and 35; B – Anti-peptide serum reactivity against synthetic peptide at a titre of 1:1,000,000 on days 7, 14 and 30. Cut-off points (horizontal solid line) were calculated at 0.087 and 0.053, respectively. **** – extremely significant difference (Tukey test P < 0.0001); *** – highly significant difference (Tukey test P < 0.0002) (n = 2); ** – significant difference (Tukey test P < 0.0021); * - significant difference (Tukey test P < 0.0332) (n = 2); C – Anti-wart serum reactivity against peptide at titres of 1 : 10,000–1 : 1,000,000 on day 14 and at a titre of 1 : 10,000 on day 35; D – Anti-peptide serum reactivity against WWL at a titre of 1 : 10,000 on days 7, 14 and 35, and at a titre of 1 : 1,000,000 on days 14 and 35. Letters a, b, and c represent significant difference based on the cut point (horizontal line) of 0.219 in both C and D (Tukey’s test P < 0.05) (n = 2)
Amino acid matches between epitope predictions in different software
Online server | L1 epitope | Position | Threshold | Score |
---|---|---|---|---|
Bepitope | 421 | 0.75 | Yes | |
ABCpred | SIL |
410 | 0.75 | 0.87 |
Bepipred | PSVLQNWEIGVQPPTSS |
394 | 0.75 | Yes |
LBtope | VQPPTSSIL |
404 | 0.75 | 85.2 |
BCEpred | 414 | 1.9 | Yes |
Underlined letters represent matches
To corroborate that the candidate peptide was specific for both BPV-1 and BPV-2, the peptide amino acid sequence was analysed in BLASTp. The result was 100% homology with the L1 sequence of BPV-1 and BPV-2 (Fig. 8), demonstrating a dual identity. Therefore, this candidate peptide was selected for chemical synthesis, and immunisation with the synthetic peptide (high purity, data not shown) was performed in a murine model.
Immunisation with synthetic peptide induced the production of specific antibodies, which possessed reactivity against the synthetic peptide (Fig. 9B) up to a 1:1,000,000 titre on days 7, 14, and 35 (P < 0.001). This contrasted with positive control immunisation of WWL inactivated against WWL (Fig. 9A), antibodies deriving from which reacted up to a 1:10,000 titre on the same days (P < 0.001). Also, a highly significant difference (P < 0.001) could be observed between titres in Figs. 9A and 9B, last on day 14, and between all dilutions on day 35 (Fig. 9B, P < 0.005).
Once it was corroborated that, despite being a hapten, it induced a considerable antibody titre, the synthetic peptide was verified as an epitope by observing whether this immunisation induced antibodies capable of detecting BPV particles in WWL. Reactivity was measured in sera from mice immunised with the synthetic peptide against WWL up to a titre of 1: 10,000 on days 14 and 35 (Fig. 9D, P < 0.05). The same was observed with positive control mouse sera against the synthetic peptide with reactivity up to a titre of 1 : 10,000 on days 7, 14 and 35 (Fig. 9C, P < 0.05), which indicates that the synthetic peptide derived from the L1 protein of BPV-1 was recognised by antibodies produced after induction by the immunisation and is indeed exposed in the capsid because of its position in the C-terminal region. The results of both assays (Figs 9C and 10) showed a peak in absorbance on day 14 (after the second dose was administered), indicating that more intensive specific antibody production in the IgG subclass is induced with subsequent doses through stimulation of adaptive immunity. Although on day 35 the absorbance peaks seemed to be shorter than those on day 14, the day on which the third dose was administered, statistically there was no difference between these days (P < 0.05).
Anti-wart serum reactivity against WWL at titres of 1 : 100–1 : 10,000 and at a titre of 1 : 100 on day 42 in anti-peptide serum against WWL. The solid line indicates the cut-off point at 0.08; **** – extremely significant difference (Tukey test P < 0.0001); *** – highly significant difference (Tukey test P < 0.0002) (n = 2); ** – significant difference (Tukey test P < 0.0021); * – significant difference (Tukey test P < 0.0332) (n = 2)
Besides the strength of antibody induction, the duration and maintenance of immunity are also important. To evaluate these factors, sera from positive control mice and mice immunised with synthetic peptide groups were assayed against WWL on day 42 by the same technique, and reactivity was observed at a 1: 100 titre in anti-peptide sera and at a 1 : 10,000 titre in positive control sera with a highly significant difference to reactivity in negative control sera (Fig. 10) (P < 0.001).
In Mexico there are limited reports of the incidence of bovine papillomatosis, and genotyping has been reported only in one state, Tamaulipas, where BPV-1 and BPV-2 were identified by amplifying an E7 gene fragment. This approach makes possible detection of a protein expressed in all infected dermal layers, not necessarily in cells permissive to the virus. The genotype was confirmed later, in the second step of sequencing, the results of which were not demonstrated (22). In contrast, we targeted L1 and L2 genes, genotype-specific sequences, and performed another sequencing for double-checking. These proteins are expressed only in keratinocytes or permissive cells in which the virus is assembled (24, 26), which highlights the importance of the sampling methodology. Bovine papillomaviruses 1 and 2 were identified in samples from Nuevo León, Veracruz, Chiapas and Tabasco, which corroborates what Rojas
In the present study, BPV-2 was only found in co-infections with BPV-1 in 59.38% of the samples. The southern states, except for Chiapas with 18.75%, showed higher percentages of co-infection compared with Nuevo León’s 25%: Tabasco had 93.75% and Veracruz 100%. This could be attributed to the breeding purpose of farms in southern states, which opens the possibility of direct and indirect infection from mother/father to the foetus, considering that transplacental infection may occur and that the virus has been reported in monocytes, blood, and semen (pellets and pre-seminal fluid) (15, 23). In the northern states, on the other hand, cattle are finished in feedlots for export to the United States and Canada.
We hypothesise that BPV-1 infection could increase susceptibility to BPV-2 co-infection by immunosuppressing cattle, as the former is the most common worldwide, and the latter was only found in co-infection with BPV-1. One of the possible mechanisms by which BPV-1 could immunosuppress the animal is by modulating TLR4: E2 and E7 proteins have been demonstrated to downregulate TLR4 in equine fibroblasts (30), and HPV E6 downregulates TLR9 action (5). The cattle incoming from southern countries carries more genotypic diversity in their viruses, and the incidence of genotypes other than BPV-1/2 is reported (18). This suggests infection by other genotypes, and the failure of our assays on two of our representative samples from farms in Tabasco and Chiapas to amplify any BPV-1/2/4 genetic material despite the cauliflower wart morphology strongly indicating BPV infection (14) points to another infecting genotype not evaluated in the present study.
Since amino acid and nucleotide L1 sequences are highly conserved (14), they are a good target for a prophylactic vaccine. We decided to employ the amino acid L1 sequences reported in online databases for
Anti-peptide sera demonstrated a strong production of antibodies, similar to the positive control that showed a titre of 1: 1,000,000 on day 35, whereas anti-peptide sera against WWL reacted up to a titre of 1: 10,000, which is why the peptide can be considered an immunogenic epitope. This showed reactivity at a higher titre, as shown by similar investigations, where sera from rabbits immunised with recombinant HPV-6b-L1 (7) showed reactivity against a synthetic peptide from the same protein (amino acids 417–437) only up to 1: 200 titre. Furthermore, reactivity was observed up to day 42 of the anti-peptide sera to WWL, coinciding with the finding of Campo (2) who also evaluated reactivity over time. An important aspect to consider is whether immunisation with a single peptide will be sufficient to endow the immune system with the capability to detect the virus. Campo found that sera from calves vaccinated with individual peptides (3 different regions from the L2 protein) responded with titres capable of detecting the peptide in ELISA, but also responded to recombinant L2a protein, confirming that the humoral response could be induced by immunisation with a single synthetic peptide (2). In addition, the synthetic peptide output by
This study demonstrates that the local BPV-1 and BPV-2 prevalence correlates with the worldwide incidence. Moreover, the nucleotide sequences of the L1 and L2 proteins were shown to be highly conserved despite being in exclusively local clades. Synthetic peptides induced considerable production of antibodies specific for BPV-1 and are thus considered an antigenic epitope and candidate for a vaccine in a bovine model.